The Pharma R&D model is certainly suffering. But it’s a lot easier to diagnose this disease than it is to prescribe a medicine.
So what would you do if you were running R&D for a multi-billion dollar pharmaceutical company? What specific advice would you give? Bruce Booth, Forbes magazine contributor, gives his thoughts. Read more